对帕金森病中突触囊泡功能障碍的新见解
Julita Chlebowicz1, Violetta Ivanova1, Jacqueline Burré1
1Brain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.
Journal of Parkinson's disease
|March 13, 2026
概括
突触囊泡 (SV) 功能障碍是帕金森病 (PD) 病理学的关键因素,影响神经递质的运输和释放. 针对这些早期的突触变化为PD提供了一个有希望的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 遗传学 是一个
背景情况:
- 帕金森病 (PD) 涉及渐进的运动和非运动症状.
- 在神经元损失之前的突触病理是PD病变的核心.
- 与PD相关的基因调节突触囊泡 (SV) 贩运,表明SV功能障碍的作用.
研究的目的:
- 审查SV功能障碍如何导致PD病理.
- 检查疾病相关蛋白对疾病循环的影响.
- 探索突触病理对大脑功能和潜在疗法的影响.
主要方法:
- 关于PD中SV功能障碍的最近研究的文献综述.
- 分析PD相关蛋白质如何影响SV贩运和SV循环.
- 检查前突触病理对后突触可塑性和电路的影响.
主要成果:
- 确定了三个关键的致病机制:神经递质进口/储存受损,破坏了 SV 池组织,以及改变了 SV 外细胞/内细胞.
- 前突触性病理引发了后突触性可塑性的损伤.
- 由于突触功能障碍,电路级重组发生在整个大脑区域.
结论:
- 前突触性SV功能障碍是PD病变发生的一个中心机制.
- 了解这些突触变化对于开发PD疗法至关重要.
- 针对早期的突触改变,为帕金森病提供了一个有前途的治疗策略.
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Fusion of Secretory Vesicles with the Plasma Membrane
19.2K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.2K
Postsynaptic Potential (PSP)
8.0K
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
8.0K


